Catalyst Wire Dossier Catalyst Wire Dossier

PT005

· Pearl Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for PT005, covering 2010-10-13 to 2019-09-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos) [Phase 3]

See pricing